Moreover, AD patients exhibited significantly lower amounts of GPX1 than the control group (FCAD/Co = 0.85; p = 1.13E−8; Figure 5C), whereas the levels in MCI patients remained unchanged (Figure 5C). Here, GPX1 is linked to Alzheimer disease.